What Is Alzheimer’s Disease
Alzheimers disease is an irreversible, progressive, degenerative disease of the brain which causes thinking and memory to become seriously injured and ultimately even the ability to carry out the simplest tasks. Mostly first Alzheimer’s signs develop after age 60. Ultimately the disease is commencing to death.
Estimates range, but experts recommend that as many as 5.1 million Americans may have Alzheimer’s.
Common Signs Associated with Alzheimer’s Disease
Much associate memory loss as the most obvious sign compared with Alzheimer’s disease. The start of Alzheimer’s disease may also indicate by other common signs other than memory loss.
Some common signs of Alzheimer’s disease typically compared with the start of the brain disease include:
- Abrupt personality changes;
- A feeling of sadness, agitation, fear, and confusion before twilight and sometimes lasting until dawn. This has been referred to as Sundowner’s Syndrome;
- Inability to cope with change;
- Withdrawal from social activities;
- Loss of interest in family and friends
While these common signs are shown to be associated with the onset of Alzheimer’s disease, they may also indicate other conditions. If a family member or loved one shows these signs, it doesn’t necessarily mean Alzheimer’s disease but maybe enough to have the individual evaluated by a medical professional.
Even though these are some common signs of Alzheimer’s disease, it is essential to keep in mind all the symptoms of Alzheimer’s when making an assessment.
Symptoms of Alzheimer’s Disease
There are several distinct symptoms associated with the onset of Alzheimer’s disease. Even those Alzheimer’s may affect different people in different ways; there are signs and symptoms of Alzheimer’s disease that are reasonably consistent with the progression of this brain disease.
Memory loss that disrupts the daily routine of a person is not necessarily aging. It may be one of the most noticeable symptoms associated with Alzheimer’s disease.
Some symptoms of Alzheimer’s disease include
- Memory loss that disrupts daily life. This is one of the most common symptoms of Alzheimer’s disease and may be characterized by forgetting things recently learned, important dates and asking for the same information multiple times.
- Changes in planning and problem solving. This symptom of Alzheimer’s may be noticeable when a person is having trouble following familiar instructions such as a recipe or performing tasks such as keeping track of bills.
- Difficulty completing familiar tasks. People developing Alzheimer’s disease may often experience difficulty completing familiar tasks.
- Confusion with time or place. People with Alzheimer’s disease tend to lose track of dates and time. People displaying this symptom of Alzheimer’s disease may forget where they are or how they got to a certain location.
- Problems with written or spoken language. People with Alzheimer’s disease may repeat themselves, forget certain words or use word substitutions.
These are some symptoms and signs of Alzheimer’s disease.
Alzheimer’s Disease Early Stage
- In the early stage: Some slight memory loss. Low personal interest in hobbies, depression and losing an attachment to life.
- In The Middle Age: Memory loss will become more severe. For example, not getting the story point or dont understand jokes, mood disturbance, anxiety.
- In The Late Stage: Speaking Inability and completely memory loss.
Risk Factors for Alzheimers Disease
The neurologists and medical community usually list the following as risk factors for Alzheimer’s.
- Obesity, and elevated, High-fat diet, cholesterol levels.
- Age and Genetics.
- Hypertension, diabetes, and atherosclerosis.
- Concussion or trauma to the head.
- Chronic depression or depression.
- Cognitive impairment.
- Hormone replacement therapy.
Alzheimer’s Disease Treatment Aricept
Alzheimers disease treatment Aricept used to treat Alzheimer’s patients that display mild to moderate symptoms of Alzheimers disease. It has also used treatment for patients with advanced Alzheimer’s disease.
Aricept is not a cure for Alzheimer’s disease but used as an Alzheimer’s treatment for people with mild, moderate, and advanced Alzheimer’s symptoms.
People with Alzheimer’s disease show a progressive degeneration in nerve cells, especially those that make acetylcholine – a chemical thought to important for both learning and memory. Alzheimer’s treatment Aricept works principally by reducing the breakdown of acetylcholine, resulting in more of this chemical is present in the brain of those who have Alzheimer’s disease.
With such an Alzheimer’s disease treatment, it has suggested based on research data that Aricept enhances the action of acetylcholine by making receptors more responsive in the brain.
People treated with Alzheimer’s disease treatment Aricept may take as long as 12 weeks to show signs of responding to drug treatment.
In recent developments, the FDA approved a generic version of Alzheimer’s disease treatment Aricept.
Alzheimer’s Disease Treatment Ebixa
Alzheimer’s disease treatment Ebixa is a drug treatment prescribed to Alzheimer’s patients that display moderate to advanced symptoms of the disease.
Ebixa is not a cure for Alzheimer’s disease but treats Alzheimer’s symptoms by stabilizing the decline in cognition and daily function.
The Alzheimer’s treatment Ebixa, one of a group of drugs classed as an NMDA receptor antagonist.
Alzheimer’s disease causes nerve cells to leak massive quantities of glutamate, which leads to excessive interaction with the NMDA receptors resulting in the disease or death of the receiving nerve cells. With Alzheimer’s disease treatment Ebixa, the drug interacts with the NMDA receptors and prevents glutamate from interacting with the receiving cells. This results in the standard transmission of nerve messages between nerve cells.
With such an Alzheimer’s disease treatment, there is a slowing in the decline of memory and cognition in those patients with Alzheimer’s disease.
Ebixa can use by itself or in conjunction with other Alzheimer’s disease treatments.
People treated with Alzheimer’s disease treatment Ebixa may take as long as 12 weeks to show signs of responding to drug treatment.
Experimental Alzheimer’s Treatment – Dimebon
An experimental Alzheimers treatment known as dimebon set to begin clinical trials.
Dimebon or dimebolin hydrochloride is an older Russian drug that commonly used as an antihistamine. Dimebon has shown to have success in preventing brain cell deaths associated with brain diseases such as Alzheimer’s.
Both pre-clinical trials and Russian research has shown dimebon as a promising new Alzheimers treatment. When used to treat Alzheimer’s patients, dimebon resulted in improved thinking, memory, and behavioral functions in early to mid-stage Alzheimer’s patients.
Entering into clinical trials as an Alzheimer’s disease treatment, dimebon hoped to provide a new therapy for Alzheimer’s disease within the next 10 years.